Human brain amyloidoses

Nephrology Dialysis Transplantation

Volumn 13, Issue SUPPL. 7, 1998, Pages 33-40

  Gambetti, P ^a   Russo, C ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PREALBUMIN;

ALZHEIMER DISEASE; AMYLOIDOSIS; BRAIN DISEASE; BRAIN HEMORRHAGE; CONFERENCE PAPER; HUMAN; PRION DISEASE; PRIORITY JOURNAL;

EID: 0031757814     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.suppl_7.33     Document Type: Conference Paper

References (53)

1. Ghiso J, Wisniewski T, Frangione B. Unifying features of systemic and cerebral amyloidosis. Mol Neurobiol 1994; 8: 49-64
2. Polymeropoulos MH, Lavedan C. Leroy E et al. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 1997; 276: 2045-2047
3. Bruijn LI, Becher MW, Lee MK et al. ALS-linked SOD1 mutant G85R mediates damage to astrocytes and promotes rapidly progressive disease with SOD1-containing inclusions. Neuron 1997; 18: 327-338
4. Scherzinger E, Lurz R, Turmaine M et al. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo. Cell 1997; 90: 549 558
5. Paulson HL, Perez MK, Trottier Y et al. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron 1997; 19: 333-344
6. Saltykow S. Zur frange des lokalen amyloidosis der hirngefabe. Virchows Arch 1935; 295: 590
7. Harris JH, Rayport M. Primary cerebral amyloidoma. J Neuropathal Exp Neurol 1979; 38: 318
8. Spaar FW, Goebel HH, Volles E, Wickboldt J. Tumor-like amyloid formation (amyloidoma) in the brain. Neurology 1981; 224: 171-182
9. Townsend JJ, Tomiyasu U, MacKay A, Wilson CB. Central nervous system amyloid presenting as a mass lesion. Report of two cases. J Neurosurg 1982; 56: 439-442
10. Hori A, Kitamoto T, Tateishi J, Hann P, Friede RL. Focal intracerebral accumulation of a novel type of amyloid protein. An early stage of cerebral amyloidoma? Acta Neuropathol (Berl) 1998; 76: 212-215
11. Cohen M, Lanska D, Roessmann U et al. Amyloidoma of the CNS. I. Clinical and pathologic study. Neurology 1992; 42: 2019 2023
12. Erikkson L, Sletten K, Benson L, Westermark P. Tumour-like localized amyloid of the brain is derived from immunoglobulin light chain. Scand J Immunol 1993; 37: 623-626
13. Linke RP, Gerhard L, Lottspeich F. Brain-restricted amyloidoma of immunoglobulin lambda-light chain origin clinically resembling multiple sclerosis. Biol Chem Hoppe Seyler 1992; 373: 1201-1209
14. Lee J, Krol G, Rosenblum M. Primary amyloidoma of the brain: CT and MR presentation. Am J Neuroradiol 1995; 16: 712-714
15. Schroeder R, Linke RP, Voges J, Heindel W, Sturm. Intracerebral A lambda amyloidoma diagnosed by stereotactic biopsy. Clin Neuropathol 1995; 14: 347-350
16. Caerts B, Mol V, Sainte T, Wilms G, Van den Bergh V, Stessens L. CT and MR1 of amyloidoma of the CNS. Eur Radiol 1997; 7: 474-476
17. Vidal RG, Ghiso J, Gallo G, Cohen M, Gambetti P, Frangione B. Amyloidoma of the CNS. II. Immunohistochemical and biochemical study. Neurology 1992; 42: 2024 2028
18. Hamilton JA, Steinrauf LK, Liepnicks J et al Alteration in molecular structure which results in disease: the Met-30 variant of human plasma transthyretin. Biochim Biophys Acta 1992; 1139: 9 16
19. Benson MD. Amyloidosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill, Inc. 1995: 4159-4191
20. Saraiva MJM. Transthyretin mutations in health and disease. Hum Mut 1996; 5: 191-196
21. Benson MD. Leptomeningeal amyloid and variant transthyretins. Am J Pathol 1996; 148: 351 354
22. Petersen RB, Goren H, Cohen M et al. Transthyretin amyloidosis: a new mutation associated with dementia. Ann Neurol 1997; 41: 307-313
23. Izumoto S, Younger D, Hays AP, Martone RL, Smith RT, Herbert J. Familial amyloidotic polyneuropathy presenting with carpal tunnel syndrome and a new transthyretin mutation, asparagine 70. Neurology 1992; 42: 2094-2102
24. Ueno S, Fujimura H, Yorifuji S et al. Familial amyloid polyneuropathy associated with the transthyretin Cys114 gene in a Japanese kindred. Brain 1992; 115: 1275 1289
25. Reilly MM, Adams D, Booth DR et al. Transthyretin gene analysis in European patients with suspected familial amyloid polyneuropathy. Brain 1995; 118: 849-856
26. Goren J, Steinberg M, Farboody GH. Familial oculoleptomeningeal amyloidosis. Brain 1980; 103: 473-495
27. Uitti RJ, Donat JR, Rozdilsky B, Schneider RJ, Koeppen AH. Familial oculoleptomeningeal amyloidosis. Report of a new family with unusual features. Arch Neurol 1988; 45: 1118 1122
28. Herbert J, Younger D, Latov N, Martone RL. Clinical spectrum of familial amyloidotic polyneuropathy. In: Kisilevsky R, Benson M, Frangione G et al., eds. Amyloid and Amyloidosis. Parthenon Publishing: New York 1994; 486-488
29. Hamburg A. Unusual cause of vitreous opacities: Primary familial amyloidosis. Ophthalmologica 1971; 162: 173-177
30. Vidal R, Garzuly F, Budka H et al. Meningocerebrovascular amyloidosis associated with a novel transthyretin mis-sense mutation at codon 18 (TTRD18G). Am J Pathol 1996; 148: 361-366
31. Okayama M, Goto I. Ogata J et al. Primary amyloidosis with familial vitreous opacities. Arch Intern Med 1978; 138: 105-111
32. Terry CJ, Damas AM. Oliveira P et al. Structure of Met30 variant of transthyretin and its amyloidogenic implications. EMBO 1993; 12: 735 741
33. Benson MD. Leptomeningeal amyloid and variant transthyretins. Am J Pathol 1996; 148: 351 354
34. Ghiso J, Wisniewski T, Frangione B. Unifying features of systemic and cerebral amyloidosis. Mol Neurobiol 1994; 8: 49 64
35. Abrahamson M. Molecular basis for amyloidosis related to hereditary brain hemorrhage. Scand J Clin Lab Invest 226 [Suppl.]: 1996; 47 56
36. Olafsson I. Thorsteinsson L. Olafur J. The molecular pathology of hereditary cystatin C amyloid angiopathy causing brain hemorrhage. Brain Pathol 1996; 6: 121-126
37. Sveinbjornsdottir S, Blondal H, Gudmundsson G, Kjartansson O, Jonsdottir S, Gudmundsson G Progressive dementia and leukoencephalopathy as the initial presentation of late onset hereditary cystatin-C amyloidosis. Clinicopathological presentation of two cases. Neurol Sci 1996; 140: 101 108
38. Selkoe DJ. Amyloid-protein and the genetics of Alzheimer's disease. J Biol Chem 1996; 271: 18295 18298
39. Robbins SL. Pathologic Basis of Disease: 5th edn. W. B. Saunders Co.: Chapter 5: Genetic disorders.
40. Selkoe DJ. Normal and abnormal biology of the β-amyloid precursor protein. Annu Rev Neurosci 1994; 17: 489 517
41. Ida N, Hartmann T, Pantel J et al. Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive western blot assay. J Biol Chem 1996; 271: 22908 22914
42. Maggio JE, Mantyh PW. Brain amyloid: a physicochemical perspective. Brain Pathol 1996; 6: 147 162
43. Tabaton M, Nunzi MG, Xue R, Usiak M, Autilio-Gambetti L, Gambetti P. Soluble amyloid β-peptide is a marker of Alzheimer amyloid in brain but not in cerebrospinal fluid. Biochem Biophys Commun Res 1994; 200: 1598-1603
44. Teller JK, Russo C, De Busk L et al. Presence of soluble β-peptide precedes amyloid plaques formation in Down's syndrome. Nature Med 1996; 2: 93-95
45. Russo C, Saido TC, DeBusk LM, Tabaton M, Gambetti P. Teller JK. Heterogeneity of water-soluble amyloid beta-peptide in Alzheimer's disease and Down's syndrome brains. FEBS Lett 1997; 409: 411-416
46. Hartmann T, Bieger SC, Bruhl B et al. Distinct sites of intracellular production for Alzheimer's disease Aβ 40/42 amyloid peptides. Nature Med 1997; 3: 1016-1020
47. Bornebroek M, Haan J, Maat-Schieman MLC, Van Duinen SG, Roos RAC. Hereditary cerebral hemorrhage with amyloidosis Dutch type (HCHWA-D): I - A review of clinical, radiologic and genetic aspects. Brain Pathol 1996; 6: 111 114
48. Levy E, Carman MD, Fernandez-Madrid IJ et al. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 1990; 248: 1124-1126
49. Castano EM, Prelli F, Soto C et al. The length of amyloid β in hereditary cerebral hemorrhage with amyloidosis, Dutch type. J Biol Chem 1996; 271: 32185 32191
50. Prusiner SB, DeArmond SJ. Prion diseases and neurodegeneration. Annu Rev Neurosci 1994; 17: 311 319
51. Come JH, Fraser PE, Lansbury PT, Jr. A kinetic model for amyloid formation in the prion diseases: importance of seeding. Proc Natl Acad Sci USA 1993; 90: 5959 5963
52. Parchi P, Gambetti P. Human prion diseases. Curr Opin Neurol 1995; 8: 286-293
53. Ghetti B, Piccardo P, Frangione B et al. Prion protein amyloidosis. Brain Pathol 1996; 6: 127 145